Login Register
English
0

Cart

$ 0

NQO1 Polyclonal Antibody

NQO1 Polyclonal Antibody

Views(3) Publications(0) Catalog no(ABP51984)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(0)
  • Comments(0)

Specification

Product name NQO1 Polyclonal Antibody
Immunogen Synthesized peptide derived from the C-terminal region of human NQO1
Host Rabbit
Reactivity Human,Rat,Mouse,
Applications WB,IF,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;IF 1:50-200;ELISA 1:10000;Not yet tested in other applications.
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative NQO1; DIA4; NMOR1; NAD(P)H dehydrogenase [quinone] 1; Azoreductase; DT-diaphorase; DTD; Menadione reductase; NAD(P)H:quinone oxidoreductase 1; Phylloquinone reductase; Quinone reductase 1; QR1

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Molecular weight 31kD
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background NQO1 is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in NQO1 have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of NAD(P)H quinone dehydrogenase 1 has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Gene ID 1728
Alternative NQO1; DIA4; NMOR1; NAD(P)H dehydrogenase [quinone] 1; Azoreductase; DT-diaphorase; DTD; Menadione reductase; NAD(P)H:quinone oxidoreductase 1; Phylloquinone reductase; Quinone reductase 1; QR1
Others NQO1 Polyclonal Antibody detects endogenous levels of NQO1 protein.
Accession P15559
Observed Band(KD) 31

Image & description

Fig.1. Western Blot analysis of various cells using NQO1 Polyclonal Antibody diluted at 1:2000.

Fig.1. Western Blot analysis of various cells using NQO1 Polyclonal Antibody diluted at 1:2000.

Fig.2. Western Blot analysis of Jurkat cells using NQO1 Polyclonal Antibody diluted at 1:2000.

Fig.2. Western Blot analysis of Jurkat cells using NQO1 Polyclonal Antibody diluted at 1:2000.

This product has been cited in0publications

Reviews

There are no reviews yet.

Be the first to review “NQO1 Polyclonal Antibody”